Omega Funds has led a $16m round for Switzerland-based Chord Therapeutics, a biopharmaceutical company that develops treatments for rare and life-threatening diseases.
France-based luxury holiday company is aiming for market consolidation following the fresh funding
Advisory firm’s first office in continental Europe will be led by director George Lyons
German centre-based tutoring provider will operate individually while synergies with new owner are identified
GP in informal discussions around exit or sale of parts of the UK-based company